%0 Generic
%T Different clinical outcome of metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to KRAS genotype and disease extension.
%A Bruera, Gemma
%A Cannita, Katia
%A Di Giacomo, Daniela
%A Lamy, Aude
%A Troncone, Giancarlo
%A Dal Mas, Antonella
%A Coletti, Gino
%A Frébourg, Thierry
%A Sabourin, Jean-Christophe
%A Tosi, Mario
%A Ficorella, Corrado
%A Ricevuto, Enrico
%I American Society of Clinical Oncology (ASCO)
%@ 1527-7755
%@ 0732-183X
%K Cancer Research
%K Oncology
%D 2012
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation